CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

Issuer: CureVac


/ Key word: Annual Results





CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update






24.04.2024 / 13:06...

Related Keywords

Germany ,Belgium ,Netherlands ,United States ,Virginia ,United Kingdom ,Texas ,Switzerland ,Federal Republic Of Germany ,German ,Sarah Fakih ,Thaminda Ramanayake ,Pierre Kemula ,Patrick Perez ,Alexander Zehnder ,University Of Rochester Simon School Business ,Clinical Trial Supply Agreement Center ,Junior ,Curevac Inc ,Exchange Commission ,Amgen ,Corporate Development ,Seasonal Flu Program ,German Federal Patent Court ,Corporate Communications ,University Of Rochester ,Biomarin Pharmaceuticals ,University Of Texas Md Anderson Cancer Center ,Rna Vaccine Program ,District Court ,Curevac Corporate Services Gmb ,German Federal Court ,German Center ,Curevac Management Team ,German Federal Ministry Of Health ,Regional Court ,Curevac Announces Financial Results ,Fourth Quarter ,Provides Business ,Pandemic Preparedness Agreement ,Federal Republic ,German Federal Ministry ,Chief Business Officer ,Chief Executive Officer ,Chief Financial Officer ,Pandemic Vaccines ,Cancer Center ,Affinit Therapeutics ,Vice President ,Global Head ,Business Development ,Rochester Simon School ,Broad Second Generation ,Jointly Developed ,Oncology Footprint ,Data Safety Monitoring Board ,Intellectual Property ,Acuitas Therapeutics ,Eastern District ,Finance Income ,Junior Manager Public ,Vice President Corporate Communications ,Curevac Manufacturing Gmbh ,Curevac Swiss ,Curevac Corporate Services Gmbh ,Curevac Belgium ,Condensed Consolidated Profit ,Operating Expenses ,